Canada markets closed

Anika Therapeutics, Inc. (ANIK)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
27.590.00 (0.00%)
At close: 04:00PM EDT
27.59 0.00 (0.00%)
After hours: 04:01PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
166,662
166,662
156,236
147,794
130,457
Cost of Revenue
63,574
63,574
62,660
64,851
61,431
Gross Profit
103,088
103,088
93,576
82,943
69,026
Operating Expenses
Research Development
32,690
32,690
28,182
27,327
23,431
Selling General and Administrative
95,847
95,847
84,794
74,096
60,063
Total Operating Expenses
128,537
128,537
112,976
101,423
83,494
Operating Income or Loss
-25,449
-25,449
-19,400
-18,480
-14,468
Total Other Income/Expenses Net
-62,190
-62,190
-
21,095
-13,854
Income Before Tax
-85,327
-85,327
-18,746
2,427
-28,624
Income Tax Expense
-2,660
-2,660
-3,887
-1,707
-4,642
Income from Continuing Operations
-82,667
-82,667
-14,859
4,134
-23,982
Net Income
-82,667
-82,667
-14,859
4,134
-23,982
Net Income available to common shareholders
-82,667
-82,667
-14,859
4,134
-23,982
Basic EPS
-1.68
-
-1.02
0.29
-1.69
Diluted EPS
-1.68
-
-1.02
0.28
-1.69
Basic Average Shares
14,649
-
14,561
14,401
14,222
Diluted Average Shares
14,649
-
14,561
14,634
14,222